These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8099165)

  • 1. Filgrastim treatment of leukaemic transformation in myelodysplastic syndrome.
    Mizuno S; Akashi K; Hirota Y; Gyoten S; Matsumoto I; Harada M; Niho Y
    Lancet; 1993 Jun; 341(8858):1475-6. PubMed ID: 8099165
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
    Negrin RS; Haeuber DH; Nagler A; Olds LC; Donlon T; Souza LM; Greenberg PL
    Ann Intern Med; 1989 Jun; 110(12):976-84. PubMed ID: 2471429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report.
    Kobayashi Y; Okabe T; Ozawa K; Chiba S; Hino M; Miyazono K; Urabe A; Takaku F
    Am J Med; 1989 Feb; 86(2):178-82. PubMed ID: 2464280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
    Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
    N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.
    Herrmann F; Lindemann A; Klein H; Lübbert M; Schulz G; Mertelsmann R
    Leukemia; 1989 May; 3(5):335-8. PubMed ID: 2654495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined GM-CSF and erythropoietin therapy in myelodysplastic syndrome].
    Egli F; Hofer S; Greminger P; Rhyner K
    Schweiz Med Wochenschr; 1989 Dec; 119(49):1777-80. PubMed ID: 2694367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked and reproducible increase in trilineage blood cell counts by administration of granulocyte colony-stimulating factor in a patient with refractory anaemia with excess blasts in transformation.
    Chiba S; Inamori K; Mitani K; Hirai H; Yazaki Y
    Br J Haematol; 1994 Mar; 86(3):665-7. PubMed ID: 7519041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory anemia with an excess of blasts developed into overt leukemia with leukothrombocytosis.
    Takahashi I; Togitani K; Yokoyama M; Aita T; Makihata K; Sunami K; Shiromoto M; Nakamura T; Kawada I; Nishimura M
    Intern Med; 1995 Jan; 34(1):28-31. PubMed ID: 7718975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current developments in the therapy of the myelodysplastic syndrome].
    de Witte T; Hermans J; van Biezen A; Runde V; Gratwohl A
    Ned Tijdschr Geneeskd; 1995 Oct; 139(42):2135-9. PubMed ID: 7477578
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost considerations in therapy with myeloid growth factors.
    Glaspy JA; Jakway J
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
    Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
    An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
    [No Abstract]   [Full Text] [Related]  

  • 12. Filgrastim for mesalazine-associated neutropenia.
    Wyatt S; Joyner MV; Daneshmend TK
    Lancet; 1993 Jun; 341(8858):1476. PubMed ID: 8099166
    [No Abstract]   [Full Text] [Related]  

  • 13. Filgrastim for low-dose, captopril-induced agranulocytosis.
    Chia HM; Kalra L; Lakhani AK; Samaratunga IR
    Lancet; 1993 Jul; 342(8866):304. PubMed ID: 8101328
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs recently released in Belgium. Filgrastim--terbinafine.
    Harvengt C
    Acta Clin Belg; 1992; 47(3):217-22. PubMed ID: 1332353
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transfusional independence in a patient with refractory anemia with excess blasts-2 refractory to 5-azacitidine treated with deferasirox and colony stimulating factors].
    Moreno de Gusmão B; Guinea de Castro JM; Perez-Persona E; Oiartzabal I
    Med Clin (Barc); 2014 Jan; 142(2):91-2. PubMed ID: 23790532
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor.
    Greenberg P; Negrin R; Nagler A; Vincent M; Donlon T
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():293-300; discussion 300-2. PubMed ID: 1691248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor.
    Greenberg P; Negrin R; Nagler A; Souza L; Donlon T
    Prog Clin Biol Res; 1990; 338():151-61. PubMed ID: 1693211
    [No Abstract]   [Full Text] [Related]  

  • 18. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic growth factors in bone marrow transplantation for hematologic malignancies.
    Lazarus HM
    Prog Clin Biol Res; 1990; 352():531-8. PubMed ID: 1698303
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.